Gilead CEO gives $1 million endowment to CU Boulder

The President and CEO of California-based Gilead Sciences has donated a $1 million endowment to CU Boulder BioFrontiers Institute.

CHLOE

The President and CEO of California-based Gilead Sciences has donated a $1 million endowment to CU Boulder BioFrontiers Institute.

The Olke C. Uhlenbeck Endowed Graduate Fund, donated by John F. Milligan and his wife, Kathryn-Bradford Milligan, will help first-year grad students in nine academic departments within the BioFrontiers Institute.

John F. Milligan spent two years during his doctoral studies at the university where he studied under the award’s namesake, Olke C. Uhlenbeck, who helped steer the university to acclaim for ribonucleic acid (RNA) research and helped found the RNA Society and the affiliated journal.

“I really value the time I spent at CU Boulder with Olke,” said Milligan in a statement. “I appreciate the conversations we had as I developed into a scientist. He also taught me to be a leader by showing me what it meant to be engaged in research and intellectually curious.”

The first $55,000 fellowship will be awarded this fall and every other year thereafter.

Multimedia business & healthcare reporter Chloe Aiello can be reached via email at caiello@denverite.com or twitter.com/chlobo_ilo.

Subscribe to Denverite’s newsletter here.